DNTH(Dianthus Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-12 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 17,724 | $90.56 |
| 2026-11-11 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 3,044 | $90.03 |
| 2026-11-10 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 2,561 | $90.14 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 2,064 | $91.59 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 58,396 | $90.90 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 37,517 | $90.12 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 1,736 | $88.84 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 700 | $86.70 |
| 2026-11-09 | Savitz Ryan | EVP, CFO & CBO | 公开市场卖出 | 300 | $85.16 |
| 2026-09-17 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 公开市场卖出 | 700 | $104.39 |
| 2026-09-17 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 公开市场卖出 | 1,100 | $103.20 |
| 2026-09-17 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 公开市场卖出 | 3,501 | $102.39 |
| 2026-09-17 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 公开市场卖出 | 6,771 | $101.37 |
| 2026-09-17 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 公开市场卖出 | 7,928 | $100.43 |
| 2026-09-01 | Randhawa Simrat | EVP, Head of R&D | 公开市场卖出 | 13,309 | $106.74 |
| 2026-09-01 | Randhawa Simrat | EVP, Head of R&D | 公开市场卖出 | 7,215 | $106.25 |
| 2026-09-01 | Randhawa Simrat | EVP, Head of R&D | 公开市场卖出 | 2,600 | $105.19 |
| 2026-08-19 | Read Simon | 董事 | 公开市场卖出 | 2,778 | $117.55 |
| 2026-08-10 | McGeorge Anne | 董事 | 公开市场卖出 | 700 | $111.41 |
| 2026-08-10 | McGeorge Anne | 董事 | 公开市场卖出 | 1,000 | $110.64 |